The U.S. Food and Drug Administration on Friday approved Pfizer ​and Arvinas' breast cancer drug for patients with an ...

Scripps Research professors Carmel Valley resident John Yates III, the John Lytton Young Endowed Chair, and Jeffery Kelly, ...

This week in Other Barks & Bites: the U.S. Trade Representative issues its annual Special 301 Report listing the European ...

Blue-chip stocks are shares of large, well-established, financially stable companies with a consistent and reliable ...

Pfizer Inc. (NYSE:PFE) is included among the 10 Innovative Dividend Stocks to Buy Right Now. On April 28, Morgan Stanley ...

The pharmaceutical giant just extended the lifespan of one of its top drugs.

Pfizer has spent the past few years trying to convince investors that its post-pandemic business can stand on its own, and ...

CEO Yvonne Greenstreet said Q1 “demonstrated continued strength of the business,” highlighting “over $900 million in total net revenues from AMVUTTRA and ONPATTRO combined” and “more than $1 billion ...

Pfizer Inc. (NYSE:PFE) is one of the most active US stocks to buy right now. On April 28, Pfizer entered into settlement ...

Pfizer has reached agreements with Dexcel Pharma, Hikma Pharmaceuticals and Cipla, regarding lawsuits filed in the U.S.

On April 28, Morgan Stanley reiterated an Equal Weight rating on Pfizer Inc. (NYSE:PFE). It also set a $28 price target on ...

Pfizer Inc. announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, regarding lawsuits filed in the US District ...